Analytical Data
-
Gene name
AKTIP
- Application
-
Alternative Names
Ft1Fused toes protein homolog
-
Species
Human
-
Source
E. coli
-
Tag
N- His-SUMO
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q9H8T0
-
Expression Region
1-292aa
-
Molecular Weight
49.1 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
The AKTIP protein, also known as AKT interacting protein, is a key regulatory molecule involved in several cellular processes, including cell survival, growth, and metabolism. Its association with the AKT signaling pathway makes it crucial in understanding cancer biology, as aberrations in this pathway are frequently observed in various malignancies. Research has shown that AKTIP interacts with AKT protein kinases, modulating their activity and influencing downstream signaling cascades that affect cell proliferation and survival. Given the central role of AKT in tumorigenesis, investigating the structure and function of AKTIP provides insights into potential therapeutic targets for cancer treatment. Recent studies have also suggested that AKTIP may play a role in other conditions, such as metabolic disorders and neurodegenerative diseases, further emphasizing its importance in both pathophysiology and potential therapeutic interventions. The ongoing exploration of AKTIP not only enhances our understanding of its biological functions but also paves the way for novel strategies in drug development aimed at diseases where AKT signaling is dysregulated.
